Document is current

Article History

Received: 26 November 2024

Revised: 3 February 2025

Accepted: 23 March 2025

First Online: 24 April 2025

Compliance with ethical standards

:

: The scientific guarantor of this publication is Prof. Francesco Sardanelli, MD.

: Outside the present work, the authors declare the following relationships with companies and institutions: F.S. declares relationships with Bayer Healthcare (consultation/speaker fees), Bracco Imaging (grant/research support), and General Electric Healthcare (speaker fee). A.C. received speaker’s fees from BD—Becton Dickinson. N.H. receives research funding via a National Breast Cancer Foundation (NBCF Australia) Breast Cancer Research Leadership Fellowship. F.J.G. received research grants from General Electric Healthcare, GSK, and Hologic, and had research collaborations with Volpara and Bayer AG. She is an NIHR senior investigator and receives funding from the Cambridge BRC. M.B.I.L. received research grants from and is a member of the speakers’ bureau of General Electric Healthcare. K.P. declares being part of speakers’ bureaus for the European Society of Breast Imaging (active), Bayer AG (ended), Siemens Healthineers (ended), IDKD 2019 (ended), and Olea Medical (ended); consulting for Genentech, Merantix Healthcare, AURA Health Technologies, and Guerbet. D.S. is affiliated with Kiwifarm S.r.l., La Morra, Italy. P.C. and K.P. are part of the Scientific Editorial Board of European Radiology (section: Breast). R.M.M. is a member of the Advisory Editorial Board of European Radiology (European Society of Breast Imaging), and R.G. is Deputy Editor of European Radiology. As such, none of them had any role in handling this manuscript, and none of them took part in the decision processes. All other authors declare that they have no conflict of interest related to the present work, and that they have nothing to disclose.

: The first three authors (A.C., G.D.L., and N.H.) have significant statistical expertise.

: Written informed consent was obtained from all patients in this study, unless waived by local Ethics Committees.

: This study was approved by the Ethics Committee of the coordinating centre on January 29, 2013 (protocol number 2784) and thereafter by local Ethics Committees of participating centres.

: This paper is a targeted subgroup analysis of 3510 patients who were previously included in the main paper of the MIPA study (Sardanelli et al []) and in the paper comparing patients with different MRI referrals (Cozzi et al []).

: